US Edition
Mexico Powers Forward with 10.4 Billion in Pharmaceutical Industry Investment
14 Articles
14 Articles
National pharmaceutical companies will invest 10,48 billion pesos in four projects as part of Plan Mexico for the following years, announced yesterday in the morning of President Claudia Sheinbaum Pardo.
Four Mexican pharmaceutical companies will invest a total of 10,480 million pesos in different projects as part of Plan Mexico, as announced this Thursday by President Claudia Sheinbaum during her morning conference. The goal of this investment, said the president, is to boost the national economy and achieve “sovereignty in pharmaceutical matters so that Mexico can cope with situations of vulnerability such as the pandemic by COVID-19′′. “For u…
Mexico powers forward with 10.4 billion in pharmaceutical industry investment
The post Mexico powers forward with 10.4 billion in pharmaceutical industry investment appeared first on Riviera Maya News. Mexico City, Mexico — President Claudia Sheinbaum has announced a 10.4 billion peso investment to strengthen the Mexican pharmaceutical industry. The objective, she said, is… The post Mexico powers forward with 10.4 billion in pharmaceutical industry investment appeared first on Riviera Maya News.
The Maya Train, together with the Ministry of Defense, launched a tender to buy 6,447 pieces of medicines and pharmaceuticals, for a cost of 379,551 pesos, through five suppliers. The military tender had no setbacks, unlike that carried out by the state company Birmex, which had to be cancelled for overprice last April, and on which the Maya Train does not depend for its medicines. It may interest you: Explota fuel pipe in section 6 of the Maya …
Mexico City, July 3. Pharmaceutical companies will invest more than 10,48 billion pesos in Mexico in the coming years, as part of their plans to expand and strengthen infrastructure to meet the demand of the national market. During their morning conference in Palacio Nacional, President Claudia Sheinbaum, noted that the companies Laboratorios Kener, Genbio, Grupo Neolpharma/BioGenTec and Grupo Neolsym “have decided to join the Mexico Plan and ha…
President Claudia Sheinbaum reported that the goal is to achieve drug sovereignty and foster national innovation in the pharmaceutical sector.
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources lean Right
To view factuality data please Upgrade to Premium
